With few exceptions, most of the 116 tumor samples and 22 controls could be analyzed successfully with the APC, CDH1, CDKN2A, EFEMP1, FHIT, L1RE1, MGMT, PTEN, RARB, and RASSF1 assays in the exploratory dataset. The gene discussed is CDKN2A; the disease is neoplasm.